Company intelligence / Profile preview

Veneto Group

United States

Ownership: Private
Development stage: Other

Overview

Veneto Group’s operating assets, including its MSO platform, eight pharmacies, a wholesale pharmacy purchasing company, and an in-network laboratory, were acquired by Generex Biotechnology in 2018 and 2019; the assets now operate as part of Generex’s service business for pharmacy, lab, and ancillary networks in the U.S.[7][9][11].

Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Veneto Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Veneto Group.

Explore the full profile